New mechanistic model for organic diisocyanate-induced respiratory disease

Schweizerische Medizinische Wochenschrift

Volumn 129, Issue 12, 1999, Pages 465-467

  Savolainen, H ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Diisocyanates; Lung disease; Mechanism; Model; Susceptibility

Indexed keywords

ISOCYANATE; ISOCYANIC ACID DERIVATIVE; POLYETHERURETHAN;

ACETYLATOR PHENOTYPE; ANTIBODY SPECIFICITY; CONFERENCE PAPER; HUMAN; NEUROGENIC INFLAMMATION; NONHUMAN; OCCUPATIONAL HAZARD; OCCUPATIONAL LUNG DISEASE; PROVOCATION TEST; RAT;

EID: 0033608798     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Vu-Duc T, Huynh C-K, Savolainen H. Les normes sur les monomères d'isocyanates protègent-elles encore contre les atteintes d'asthme professionnel? Faut-il évoluer vers une norme incluant les polyisocyanatcs? Schweiz Med Wochenschr 1997;127:2000-7.
2. Jost M, Rüegger M, Hofman M. Isocyanatbedingte Atemwegserkrankungen in der Schweiz. Schweiz Med Wochenschr 1990;120:1339-47.
3. Tarlo S, Liss GM, Dias C, Banks DE. Assessment of the relationship between isocyanate exposure levels and occupational asthma. Am J Ind Med 1997;32:517-21.
4. Bernstein JA. Overview of diisocyanate occupational asthma. Toxicology 1996;111:181-9.
5. Wass U, Belin L. Immunological specificity of isocyanate-induced IgE antibodies in serum from 10 sensitized workers. J All Clin Immunol 1989;83:126-35.
6. Sheppard D, Thompson JE, Scypinski L, Dusser D, Nadel JA, Borson DA. Toluene diisocyanate increases airway responsiveness to substance P and decreases airway neutral endopeptidase. J Clin Invest 1988;81:1111-5.
7. Mapp CE, Chitano P, Fabbri LM, Patacchini R, Santicioli P, Geppetti P, et al. Evidence that toluene diisocyanate activates the efferent function of capsaicin-sensitive primary afferents. Eur J Pharmacol 1990;180:113-8.
8. Mapp CE, Boniotti A, Papi A, Chitano P, Coser E, Di Stefano A, et al. The effect of compound 48/80 on contractions induced by toluene diisocyanate in isolated guinea-pig bronchus. Eur J Pharmacol 1993;248:67-73.
9. Kalubi B, Takeda N, Irifune W, Ogino S, Abe Y, Su-Ling H, et al. Nasal mucosa sensitization with toluene diisocyanate (TDI) increases preprotachykinin A (PPTA) and prepro CGRP mRNAs in guinea pig trigeminal ganglion neurons. Brain Res 1992;576:287-96.
10. Banks DE, Rando RJ, Barkman HWJR. Persistence of toluene diisocyanate-induced asthma despite negligible workplace exposures. Chest 1990;97:121-5.
11. Paggiano P, Bacci E, Paoletti P, Bernard P, Dente FL, Marchetti G, et al. Bronchoalveolar lavage and morphology of the airways after cessation of exposure in asthmatic subjects sensitized to toluene diisocyanate. Chest 1990;98:536-42.
12. Saetta M, Maestrelli P, Turato G, Mapp CE, Milani G, Pivirotto F, et al. Airway wall remodelling after cessation of exposure to isocyanates in sensitized asthmatic subjects. Am J Respir Crit Care Med 1995;151:489-94.
13. Berode M, Testa B, Savolainen H. Bicarbonate-catalyzed hydrolysis of hexamethylene diisocyanate to 1,6-diaminohexane. Toxicol Lett 1991;56:173-8.
14. Hildebrand M, Seifert W. Determinatin of acetylator phenotype in Caucasians with caffeine. Eur J Clin Pharmacol 1989;37:525-6.
15. Rosenberg C, Savolainen H. Mass fragmenrographic determination of urinary amine metabolites in rats exposed to degradation products from heated rigid polyurethane. J Chromatogr 1986;358:385-91.
16. Rosenberg C, Savolainen H. Determination of occupational exposure to toluene cliisocyanate by biological monitoring. J Chromatogr 1986;367:385-92.
17. Rosenberg C, Savolainen H. Determination in urine of diisocyanate-derived amines from occupational exposure by gas chromatography - mass fragmentography. Analyst 1986;111:1069-71.
18. Dean RT, Jessup W, Roberts CR. Effects of exogenous amines on mammalian cells, with particular reference to membrane flow. Biochem J 1984;217:27-40.
19. Khan NIF, Boor PJ, Gu Y, Alcock NW, Ansari GAS. Oxidative stress in the splenotoxicity of aniline. Fundam Appl Toxicol 1997;35:22-30.
20. Johannsen FR, Levinskas CJ, Ben-Dyke R, Hogan GK. Subchronic inhalation toxicity of hexamethylenediamine in rats. Fundam Appl Toxicol 1987;9:504-11.
21. Gallo G, Ghiringhelli L. Patologia professionale da esametilendiamina. Med Lav 1958;49:683-9.
22. Foster JR, Smith LL, Hext PIVI, Brammer A, Soames AR, Wyatt L. Target cell toxicity of inhaled spermidine in rat lungs. Int J Exp Path 1990;71:617-30.
23. 1antitrypsin by 1,6-hexane diamine in vitro. Biochem Int 1988;17:141-5.
24. Berode M. Detoxification of an aliphatic amine by N-acetylation: experimental and clinical studies. Biochem Int 1991; 24:947-50.
25. Machovich R, Owen WG. 6-aminohexanoate and chloride ion in the activation by urokinase of porcine plasminogen. Biochim Biophys Acta 1990;1040:109-11.
26. Boetuju LW, Hanna PE. Arylamine-nucleoside adduct formation: evidence for arylnitrene involvement in the reactions of an N-acetoxyarylamine. Chem Res Toxicol 1994;7:684-9.
27. Day BW, Jin R, Basalyga DM, Kramarik JA, Karol M. Formation, solvolysis, and transcarbamylation reactions of bis (S-glutathionyl)adducts of 2,4- and 2,6-diisocyanatotoluene. Chem Res Toxicol 1997;10:424-31.
28. Sepai O, Henschler D, Sabbioni G. Albumin adducts, henioglobin adducts and urinary metabolites in workers exposed to 4,4'-methylenediphenyl diisocyanate. Carcinogenesis 1995;16:2583-7.
29. Diller WF. Arbeitsmedizinische Gesichtspunkte bei der Begutachtung des «Isocyanat-Asthmas». Arbeits Soz Präventivmed 1991;26:393-8.
30. Alexandersson R, Plato N, Kolmodin-Hedman B, Hedenstierna G. Exposure, lung function, and symptoms in car painters exposed to hexamethylendiisocyanate and biuret modified hexamethylendiisocyanate. Arch Fnvir Hlth 1987; 42:367-73.
31. Tornling G, Alexandersson R, Hedenstierna G, Plato N. Decreased lung function and exposure to diisocyanates (HDI and HDI-BT) in car repair painters: observations on reexamination 6 years after the initial study. Am J Ind Med 1990;17:299-310.